Pollogen to showcase at World Congress of Dermatology their latest non-surgical technologies that provide a new level of facial and body rejuvenation

Thursday, July 23rd, 2015

(PRWEB) June 02, 2015

Pollogen Ltd. will showcase its latest technologies in their booth (1427) at the World Congress of Dermatology (WCD) in Vancouver, Canada June 9-12. Pollogen proven technologies have set new standards for optimal facial and body contouring, dermal volumizing, wrinkle, scar and cellulite reduction. These new technologies are now found in Pollogen’s latest medical aesthetic devices the Pollogen LEGEND with VoluDerm and the geneO+ with OxyGeneo. Pollogen technologies provide treatments that are non-surgical, results that are immediate and long term, with no discomfort and no downtime.

VoluDerm facial rejuvenation treatment – An optimal combination of fine micro-needles and radio frequency for dermal volumizing, wrinkle reduction, and facial skin contouring with no pain or downtime. A recent study published by Dr. Steven D. Shapiro concluded that VoluDerm treatments demonstrated “significant dermal volume enhancement, reduction of wrinkles including nasolabial folds, perioral and periorbital lines. Improvement of neck skin laxity and skin texture, were manifested by radiant skin, smaller pores and general volume increase”.

OxyGeneo– A new facial technology providing a 3-in-1 Super Facial treatment: exfoliation, infusion, and oxygenation. The OxyGeneo treatment is now offered at select Four Season spas.

Pollogen technologies are clinically proven with over 16 articles in peer reviewed journals and is available in 60+ countries and their technologies are cleared by FDA, CE and Canadian MOH. The Company’s premier brands and technologies include: TriPollar®, OxyGeneo®, Hybrid Energy™, VoluDerm™, TriLipo and TriFractional™

The WCD is the world’s oldest continuous international dermatology meeting where the international community of dermatologists meets to discuss breakthrough technologies that are changing the face of beauty in cosmetics and aesthetic medicine, latest findings and leading industry leaders display the most advanced technologies and products.

Pollogen’s CEO, Mr. Amichai Bar-Nir stated: “Pollogen is proud to present its innovative VoluDerm treatment in the 2015 WCD. VoluDerm combines the best aspects of micro-needling and radio frequency in one treatment providing visible results and younger-looking skin. Same as our other Pollogen treatments, it can be done in simple ‘walk in – walk out’ procedures.

About Pollogen

We believe in constantly challenging ourselves to create the most advanced, effective medical aesthetic technologies and solutions.

We believe in thinking differently.

In everything we do, we take a customer-centric approach by making our products user-friendly, safe and convenient. We believe in finding ways to develop technologies that work with the body’s natural mechanisms so beautiful results are generated from within.

Pollogen is the developer and manufacturer of five revolutionary technologies under the industry premier brand names OxyGeneo®, VoluDerm™, Hybrid Energy™, TriPollar®, TriLipo® and TriFractional™. We offer a full line of clinically-proven, safe and effective, non-invasive anti-aging facial and body contouring treatment platforms for a wide range of aesthetic applications. Pollogen provides solutions for professionals in over 60 countries, addressing the specific needs and dynamic changes unique to the ever-evolving aesthetic industry

Related Natural Cosmetics Press Releases

LUTRONIC’s Innovative Aesthetic and Medical Products Featured at the 13th Anti-Aging Medicine World Congress

Wednesday, April 22nd, 2015

Fremont, CA (PRWEB) April 02, 2015

Lutronic, a leading innovator of aesthetic and medical technology, announced today that it expands its portfolio of innovative medical solutions in Europe with ACTION II Petit Lady ™ at the 13th Anti-Aging Medicine World Congress (AMWC) in Monte-Carlo, Monaco, from March 26-28, 2015. ACTION II is a device that provides a new dimension in Er:YAG laser technology applied for both gynecological and aesthetic indications. It received CE mark clearance for treatment of vaginal relaxation syndrome (VRS) and stress urinary incontinence (SUI) in June 2014, which expands its clinical applications and builds on the success of the original ACTION II device which primarily focused on aesthetic treatments.

“I have seen that ACTION II Petit Lady increases the elasticity of the vaginal wall with a significantly short downtime. Patients suffering from vaginal relaxation syndrome are very satisfied with Petit Lady because this 15-minute non-surgical treatment successfully rejuvenates the vagina and enhances sexual gratification,” said Dr Fabio Marini, a surgeon at the Skin Laser Clinic, in Italy. Dr Marini was presenting on the Petit Lady system at a special dinner Symposium during the AMWC, ‘Symposia L’, hosted by Lutronic. Dr Marini also presented his one year clinical study on ACTION II Petit Lady for vaginal atrophy and vaginal relaxation syndrome, which showed significant improvements in both sets of patients.

The well-attended symposium, which was moderated by Dr R Glen Calderhead, VP Medicoscientific Affairs for Lutronic, also featured Dr. Matteo Tretti Clementoni, a plastic surgeon at Skin House in Italy Dr Clementoni, a world-renowned physician, shared his knowledge of the INFINI™ for treating neck and low face laxity with its High Intensity Focused RF. “The device is very easy to use, and it is possible to perform full face and neck treatment in less than 15 minutes. With varying energy, pulse duration, depth of needles penetration and number of passages, it is possible to customize the treatment for the specific skin needs of each patient on an individual basis. Finally, we have a device/treatment that really allows us to obtain good results on the lower 1/3 of the face and the neck,” he added. Another presenter of INFINI, Dr Harryono Judodihardjo, a dermatologist from the Cellite Clinic, UK also shared his clinical experiences with the title, ‘How to Smooth Out Accordion Lines (Smile Lines).’

Another star speaker was Dr Christine Dierickx, a world-wide respected dermatologist from Skinperium, Belgium, who presented on the Q-switched Nd:YAG-based multiplatform, SPECTRA XT™, which is the latest edition of the cutting-edge SPECTRA family of lasers, already best-known and appreciated for its versatility and reliability.

The symposium was a great success, judging from the many favorable comments from the attendees who were most impressed by the practical and solid nature of the presentations and the range of topics covered by the well-appreciated presenters. This symposium built on the success of the similar event at last year’s AMWC, and many of those present stated that they would definitely be looking to attend again next year, hoping that it will become a tradition to be established by Lutronic at subsequent AMWC meetings.

About ACTION II Petit Lady

The Lutronic ACTION Petit Lady is a 360° solution for cosmetic gynecology. The treatment is gentle, simple and fast. The ACTION II Petit Lady 360° handpiece is specially designed for VRS. It delivers multiple micropulses to the vaginal mucosa to stimulate collagen remodeling and tighten the vaginal canal. The ACTION II Petit Lady 90º handpiece is intended for SUI, providing an enhanced thermal and shrinkage effect in the endopelvic fascia, ligaments, and mucosal tissue of the anterior vaginal canal.

To learn more about the ACTION II Petit Lady, please visit: http://www.petitlady.net/


Lutronic, a leading innovator in advanced aesthetic and medical laser and related technology, was established over 18 years ago to bring intuitive, robust, versatile devices that are affordable and efficacious to the worldwide medical community. Committed to improving medicine, Lutronic partners with key opinion leaders to advance science and ensure the efficacy of its systems. All systems are versatile and offer multiple setting and treatment options for customized treatments, which optimize outcomes for a wide variety of conditions and treatments including melasma, tattoo removal, soft tissue incision, vascular lesions, hair removal, wrinkle reduction, skin resurfacing, body/facial contouring, chronic pain and more.

With a focus on physician needs and patient outcomes, Lutronic dedicates time and funding toward the development of devices that offer features and improvements not found in today’s market. Devoting more than 20% of revenues to R&D, Lutronic holds more than 240 intellectual properties including current and pending patents worldwide. With more than 250 employees worldwide, Lutronic has offices in the US, Korea, China, Japan, and Europe, a worldwide network of distributors, and is ever expanding.

For more information about Lutronic and its products, please visit: http://www.lutronic.com

ThermiGyn to Announce Vulvovaginal Breakthroughs in Non-Surgical Vaginal Rejuvenation at IMCAS World Conference

Wednesday, February 11th, 2015

Paris, France (PRWEB) January 28, 2015

ThermiGyn, a wholly owned subsidiary of ThermiHealth, a world leader in thermistor-regulated energy solutions for medical and aesthetic applications, will announce breakthroughs in non-surgical vaginal rejuvenation at the 17th Annual IMCAS World Conference in Paris on January 30th.

Aging, loss of collagen, and vaginal births can result in vulvolaxity and dryness both internally and externally. Pelvic organ prolapse, tissue stretching, and nerve impairment are known impediments of sexual satisfaction and well-being. Red Alinsod, MD, FACOG, FACS, ACGE will present the findings of a pilot study using the ThermiVa procedure to treat vulvovaginal tissue using temperature controlled radio frequency. Dr. Alinsod is a global leader in the area of temperature controlled RF for the treatment of vulvovaginal laxity, and he is the Chairman of the ThermiGyn Women’s Health Advisory Clinical Board.

In this pilot study, both vulvar laxity and vaginal laxity improved significantly for all patients after the first treatment and continued to improve after the third and final treatment. All participants reported improvement of sexual satisfaction as a result of the treatment. The primary endpoint of vulvovaginal tightening was achieved in all patients, and secondary endpoints of improved vaginal moisture and improved continence was achieved in selected patients with prior conditions. A larger multi-site IRB study has been approved, and participants are currently being selected.

Dr. Alinsod noted, “The potential for a simple and safe temperature controlled RF device to treat vulvovaginal laxity, atrophic vaginitis, mild to moderate stress incontinence, overactive bladder, and orgasmic dysfunctions holds great promise and could be transformational.”

ThermiHealth Technology

ThermiHealth Systems integrate precise thermistor controlled micro-invasive and non-invasive applicators into unique multiuse platforms. The micro-invasive applicators are true surgeons’ tools that provide surgeons a safe and effective instrument. Both the micro-invasive and the non-invasive applicators help the operator insure that specific tissue temperatures are achieved, maintained and monitored during procedures to help ensure safety and maximize results.

The ThermiAesthetics flagship product is the ThermiRF Temperature Controlled Radio Frequency Generator System and is FDA cleared for dermatological and general surgical procedures for electrocoagulation and hemostasis, and to create lesions in nervous tissue.

About ThermiHealth

ThermiHealth is a privately held company developing a broad range of uses for thermistor controlled radio frequency technologies and for applications in the medical and aesthetic marketplaces.

ThermiAesthetics, a Division of ThermiHealth, provides advanced technology using finely controlled thermal energy. The multi-use platform, promotes increased patient safety and clinical effectiveness, while providing versatile micro-invasive and non-invasive solutions for Plastic Surgeons, Facial Plastic Surgeons, Dermatologist, Cosmetic Surgeons and other physicians serving the aesthetic market.

ThermiGyn, a wholly owned subsidiary of ThermiHealth, provides advanced technology using finely controlled thermal energy. The multi-use platform, promotes increased patient safety and clinical effectiveness, while providing versatile micro-invasive and non-invasive solutions for OB GYNs serving the women’s health marketplace.

ThermiEye, a wholly owned subsidiary of ThermiHealth, provides advanced technology using finely controlled thermal energy. The multi-use platform, promotes increased patient safety and clinical effectiveness, while providing versatile micro-invasive and non-invasive solutions for Ophthalmologists, Ocular Plastic Surgeons and other physicians serving the aesthetic market

For more information about ThermiHealth Companies, please visit http://www.thermi.com.


Michael D. Shetler and Shetler Security Services Provide Global Security Solutions For Entities All over the World

Saturday, February 7th, 2015

Phoenix, AZ (PRWEB) January 17, 2015

Shetler Security Services performs security assessments for some of the biggest brand names in the world, and in light of the recent “Je Suis Charlie” deadly shooting massacre at the Paris office of a satirical magazine, it’s not hard to see why by the end of this year, the company will have done work in approximately 40 countries around the globe.

“The truth is scary, our world has been turned upside down, and the scary thing is that it’s all real,” intones a somber Michael D. Shetler, CEO of Shetler Security Services. “I unfortunately see this kind of terrorism going on for decades because there are a lot of tormented people in this world. Lone wolf attacks, together with trained fighters who return to once peaceful countries with a burning desire to continue fighting for their cause, mean that the need for vigilance will only increase.”

For companies like the one affected in Paris, Shetler provides guards and roving patrols, and in best case scenarios for vulnerable brands, employees are trained to protect themselves through active shooter programs where participants learn basic techniques such as how to make yourself inconspicuous and hide.

Shetler is also very cognizant of the fact that public perception also affects behavior.

“These acts of domestic and international terror have a ripple effect and it often impacts the economy of the entire area where the incident took place,” reflects Shetler. “After 9-11, tourism dwindled in New York, and people in the city stayed home – it really shut things down.”

Shetler has a vested interest in this type of public perception as the biggest sporting event in America; Super Bowl XLIX will this year be hosted in the company’s own backyard at the University of Phoenix Stadium in Glendale, Arizona.

“The NFL does a tremendous job of securing the game and their stadiums, and together with city, county and state law enforcement personnel, you can expect a safe, fantastic experience while you’re here in the valley of the sun,” notes a confident Shetler.

Shetler points out that for years, the NFL has utilized sophisticated video security techniques such as facial recognition software to ensure that people who are not supposed to be at these events are detected and apprehended well ahead of time.

In the past, when Shetler was President of AT Systems Security, Inc., the company provided security services to Sky Harbor International Airport in Phoenix, AZ. This experience allows Shetler to offer a crucial tip for fans flocking to the desert for the big game.

“You know it’s going to be crowded, so be patient, but I’d also suggest enrolling in the TSA Pre✓™ , which is an expedited screening program that allows travelers to leave on their shoes, light outwear and belt, as well as keep your laptop and cosmetics in your bag,” notes Shetler.

Along with the known traveler program, Shetler also offers some practical tips once you’re in town for the big game:

    Be vigilant and report any suspicious activity, such as people who don’t’ fit in. If someone’s wearing a long trench coat and it’s 80 degrees, something may not be right
    Even if you are a former football player, don’t handle dangerous situations by yourself. Contact local law enforcement instead of confronting suspects, and call 9-1-1 if you really feel like you’re in danger
    Carry your wallet in your front pocket, and women should carry their purses in front or concealed rather than open or over your shoulder or back
    Don’t use your ATM cards in dark or desolate locations, and be wary of any requests for your personal data, as information like your social security number and cell phone number are the most highly coveted assets among thieves
     Use common sense like locking your rental car and placing any valuables out of sight, and in the trunk

Last, but not least, human nature being what it is means that the sex trade will also be in the Phoenix metro area, and prostitutes and pimps will be available to lure even the most seasoned traveler.

“You can expect that law enforcement will be closely monitoring this type of illegal activity,” warns Shetler. “Why pay for a ticket to the Super Bowl, and then pay for it with jail time by doing something stupid?”

Phoenix, like Paris, also employs a sophisticated amount of cameras and video surveillance technology, and in most every public place, you’re most likely being recorded. But people, just like famous brands, have to remain vigilant according to Shetler:

“We really all need every day security, at home and abroad. And remember, large brand companies, just like U.S. citizens, can become a target, anywhere in the world, just because of their American origin.”


Shetler Security International provides security services for some of the most well-known financial institutions in the United States, private companies, universities and large events. Their staff has over a century of supervisory and executive command level law enforcement experience. This extensive and diversified combination of training, education and experience positions Shetler Security International to conduct expert consultation, evaluation, assessment and implementation of a wide variety of security industry needs, including guard and roving patrol, corporate and executive security, diplomatic and foreign theater security and technology solutions. For more information, please visit: http://www.shetlersecurity.com.

Find More Natural Cosmetics Press Releases

Manufacturers of Simply Slick Comment on Recent FDA Changes and World Health Organization Findings on Personal Lubricants. Is Safe Sex Safe?

Saturday, November 29th, 2014

Janesville, Wisconsin (PRWEB) November 21, 2014

Recent research by the World Health Organization (WHO) [1] suggests that many conventional personal lubricants may actually be putting users at higher risk of contracting sexually transmitted diseases. These findings have triggered a new round of FDA reviews for all personal lubricants being sold in the United States. By December 31, 2015, the FDA will re-review all devices subject to a PMA (Premarket Approval) which includes Personal Lubricants. [2]

The review of the personal lubricant category has drawn comparisons to early investigations into smoking safety. In 1964, the Surgeon General of the US Public Health Service linked higher rates of lung cancer to the widespread use of cigarettes. The World Health Organization’s recent investigations have found similar links between the rapid spread of AIDs in Africa and the mass distribution of condoms and condom safe lubricant – a conclusion that on the surface seems contradictory. [1]

Key ingredients in many conventional personal lubricants are the same as those used in products designed to push a dosage of drug into the body through formats such as “the patch”. As an example, such devices are used to discharge nicotine into the body through a nicotine patch. Thus, one hypothesis is that the lubricant actually contains ingredients that facilitate the passage of STDs through the protective wall of the area rubbed against during sex. [3]

Just as the safety of cigarettes was called into question in the sixties, consumers today need to be aware of the potential link between STDs and the lubricant they take to bed.

The category review is underway, and we can expect to see fewer personal lubricants on the shelf at the end of 2015. To achieve FDA clearance, lubricant manufacturers must pass comprehensive laboratory tests. These tests are designed to ensure that the product meets the appropriate provisions of the Federal Food, Drug and Cosmetics Act for good manufacturing practice, labeling and prohibitions against misbranding and adulteration. All Personal Lubricants must have an FDA 510(k) clearance before they go to market. [4]

The first natural product to achieve FDA clearance under the new protocols is an organic, oil-based, and condom-safe, personal lubricant called Simply Slick, a newcomer brand that has already condemned mainstream manufacturers for putting profit before people – a complaint that could become more mainstream with increased consumer awareness. [5]

What else does the FDA know about the inadequacies of the personal lubricant category? Why has it taken so long for us to question the safety of personal lubricants, a product that is regularly used by millions of Americans? Did the manufacturers know about this and choose to ignore it? [6] [7]

In a study performed by the CSHP at the School of Public Health in Bloomington at Indiana University, they determined that an estimated 65% of women and 70% of men have used a personal lubricant. [8] Consumers need to seriously question their product choices. Don’t put yourself at risk under the pretense that safe sex is really safe.


Rob Leary

Simply Solutions LLC






[1] apps.who.int/iris/bitstream/10665/76580/1/WHO_RHR_12.33_eng.pdf

[2] fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDRH/CDRHVisionandMission/ucm384132.htm

[3] ncbi.nlm.nih.gov/pmc/articles/PMC3161103/

[4] fda.gov/medicaldevices/deviceregulationandguidance/howtomarketyourdevice/premarketsubmissions/premarketnotification510k/default.htm

[5] accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K140304

[6] aboutlawsuits.com/k-y-recall-42469/

[7] justice.gov/opa/pr/justice-department-sues-los-angeles-pharmaceutical-company-over-feminine-health-drug-products

[8] stdcentral.org/SHC/SHC_Reece.pdf

[9] cen.acs.org/articles/90/i50/Studies-Raise-Questions-Safety-Personal.html